145 related articles for article (PubMed ID: 32134675)
1. Reduction of Punch-Sticking Propensity of Celecoxib by Spherical Crystallization via Polymer Assisted Quasi-Emulsion Solvent Diffusion.
Chen H; Paul S; Xu H; Wang K; Mahanthappa MK; Sun CC
Mol Pharm; 2020 Apr; 17(4):1387-1396. PubMed ID: 32134675
[TBL] [Abstract][Full Text] [Related]
2. Modulating Sticking Propensity of Pharmaceuticals Through Excipient Selection in a Direct Compression Tablet Formulation.
Paul S; Sun CC
Pharm Res; 2018 Mar; 35(6):113. PubMed ID: 29603027
[TBL] [Abstract][Full Text] [Related]
3. Towards a better understanding of the role of stabilizers in QESD crystallizations.
Hansen J; Kleinebudde P
Pharm Res; 2022 Dec; 39(12):3123-3136. PubMed ID: 35266086
[TBL] [Abstract][Full Text] [Related]
4. Enabling direct compression tablet formulation of celecoxib by simultaneously eliminating punch sticking, improving manufacturability, and enhancing dissolution through co-processing with a mesoporous carrier.
Paul S; Guo Y; Wang C; Dun J; Calvin Sun C
Int J Pharm; 2023 Jun; 641():123041. PubMed ID: 37201765
[TBL] [Abstract][Full Text] [Related]
5. Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods.
Chen H; Wang C; Kang H; Zhi B; Haynes CL; Aburub A; Sun CC
Int J Pharm; 2020 Jan; 574():118914. PubMed ID: 31811924
[TBL] [Abstract][Full Text] [Related]
6. Improving flowability and reducing storage agglomeration of metformin hydrochloride through QESD crystallization.
Hansen J; Kleinebudde P
Eur J Pharm Biopharm; 2021 Feb; 159():170-176. PubMed ID: 33460735
[TBL] [Abstract][Full Text] [Related]
7. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
Xie T; Taylor LS
Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
[TBL] [Abstract][Full Text] [Related]
8. Investigation on Formulation Strategies to Mitigate Compression-Induced Destabilization in Supersaturated Celecoxib Amorphous Solid Dispersions.
Be Rziņš KR; Fraser-Miller SJ; Walker GF; Rades T; Gordon KC
Mol Pharm; 2021 Oct; 18(10):3882-3893. PubMed ID: 34529437
[TBL] [Abstract][Full Text] [Related]
9. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
[TBL] [Abstract][Full Text] [Related]
10. Enabling the direct compression of metformin hydrochloride through QESD crystallization.
Hansen J; Kleinebudde P
Int J Pharm; 2021 Aug; 605():120796. PubMed ID: 34119580
[TBL] [Abstract][Full Text] [Related]
11. Agglomeration of Celecoxib by Quasi Emulsion Solvent Diffusion Method: Effect of Stabilizer.
Maghsoodi M; Nokhodchi A
Adv Pharm Bull; 2016 Dec; 6(4):607-616. PubMed ID: 28101468
[No Abstract] [Full Text] [Related]
12. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
Van Nguyen H; Nguyen VH; Lee BJ
Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
[TBL] [Abstract][Full Text] [Related]
13. Mechanism and Kinetics of Punch Sticking of Pharmaceuticals.
Paul S; Taylor LJ; Murphy B; Krzyzaniak J; Dawson N; Mullarney MP; Meenan P; Sun CC
J Pharm Sci; 2017 Jan; 106(1):151-158. PubMed ID: 27649886
[TBL] [Abstract][Full Text] [Related]
14. Influence of Hydroxypropyl Methylcellulose on Metronidazole Crystallinity in Spray-Congealed Polyethylene Glycol Microparticles and Its Impact with Various Additives on Metronidazole Release.
Oh CM; Heng PW; Chan LW
AAPS PharmSciTech; 2015 Dec; 16(6):1357-67. PubMed ID: 25933626
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Flowability of Lamivudine through Quasi-Emulsion Solvent-Diffusion (QESD) Crystallization: A Comprehensive Study on Surfactant Impact, Particle Morphology by QbD concepts and Tablet Compression Challenges.
Sreeharsha N; Gajula LR; S SK; Bhavani PD; Goudanavar P; A R; Naveen NR; Shiroorkar PN; Meravanige G; Telsang M; Asif AH; Sreenivasalu PKP
Eur J Pharm Sci; 2024 Jun; ():106835. PubMed ID: 38908413
[TBL] [Abstract][Full Text] [Related]
16. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
Xie T; Taylor LS
Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
[TBL] [Abstract][Full Text] [Related]
17. Understanding the role of magnesium stearate in lowering punch sticking propensity of drugs during compression.
Gunawardana CA; Kong A; Wanapun D; Blackwood DO; Travis Powell C; Krzyzaniak JF; Thomas MC; Kresevic JE; Sun CC
Int J Pharm; 2023 Jun; 640():123016. PubMed ID: 37156307
[TBL] [Abstract][Full Text] [Related]
18. Direct Compression Tablet Containing 99% Active Ingredient-A Tale of Spherical Crystallization.
Chen H; Aburub A; Sun CC
J Pharm Sci; 2019 Apr; 108(4):1396-1400. PubMed ID: 30448523
[TBL] [Abstract][Full Text] [Related]
19. A novel co-processing method to manufacture an API for extended release formulation via formation of agglomerates of active ingredient and hydroxypropyl methylcellulose during crystallization.
Rosenbaum T; Erdemir D; Chang SY; Kientzler D; Wang S; Chan SH; Brown J; Hanley S; Kiang S
Drug Dev Ind Pharm; 2018 Oct; 44(10):1606-1612. PubMed ID: 29916275
[TBL] [Abstract][Full Text] [Related]
20. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
Sarpal K; Tower CW; Munson EJ
Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
